Regarding serum tumor markers, cytokeratin-19 fragment (CYFRA 21-1) and carcinoembryonic antigen have been proven to be prognostic indicators for NSCLC patients[29,30]. This evidence concerns the gene KRT19 and non-small cell lung carcinoma.